Plerixafor is safe and efficacious for mobilization of peripheral blood stem cells in pediatric patients.

about

Mobilization, Isolation and Characterization of Stem Cells from Peripheral Blood: a Systematic Review How do we mobilize and collect autologous peripheral blood stem cells?

P2860

Q33652381-97383F53-CD08-4190-A5A7-79B161CB8360 Q38978669-1C3A95AB-78C1-4E10-91D7-2006A7BBD6D8

P2860

Plerixafor is safe and efficacious for mobilization of peripheral blood stem cells in pediatric patients.

Item

http://www.wikidata.org/entity/Q38808625

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Plerixafor is safe and efficac ...... m cells in pediatric patients.

@en

type

Item

label

Plerixafor is safe and efficac ...... m cells in pediatric patients.

@en

prefLabel

Plerixafor is safe and efficac ...... m cells in pediatric patients.

@en

P1476

Plerixafor is safe and efficac ...... m cells in pediatric patients.

@en

P2093

Ashley Teusink

http://www.w3.org/2001/XMLSchema#string

Mark Mueller

http://www.w3.org/2001/XMLSchema#string

Sonata Jodele

http://www.w3.org/2001/XMLSchema#string

Stella Davies

http://www.w3.org/2001/XMLSchema#string

Susan Pinkard

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies

Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia.

A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers.

Physiology and pharmacology of plerixafor.

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantatio

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients.

Mobilization of hematopoietic stem cells by plerixafor alone in children: a sequential Bayesian trial.

Plerixafor plus G-CSF in combination with chemotherapy for stem cell mobilization in a pediatric patient with Ewing's sarcoma.

Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs.

P304

1402-1405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.13599

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27079854

http://www.w3.org/2001/XMLSchema#string

Plerixafor is safe and efficacious for mobilization of peripheral blood stem cells in pediatric patients.

about

P2860

P2860

Plerixafor is safe and efficacious for mobilization of peripheral blood stem cells in pediatric patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698